Cargando…
Severe thrombocytopenia related to trastuzumab infusion
BACKGROUND: Trastuzumab is a humanized, monoclonal antibody that interferes with the HER2/neu receptor and binds selectively to the HERB2 protein which causes uncontrolled proliferation of malignant breast cells. CASE REPORT: We report a case of severe thrombocytopenia related to trastuzumab adminis...
Autores principales: | Mantzourani, Marina, Gogas, Helen, Katsandris, Aikaterini, Meletis, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539572/ https://www.ncbi.nlm.nih.gov/pubmed/21709639 http://dx.doi.org/10.12659/MSM.881838 |
Ejemplares similares
-
Severe thrombocytopenia after trastuzumab retreatment: a case report
por: Pino, Maria Simona, et al.
Publicado: (2013) -
Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment
por: Zhou, Qiong, et al.
Publicado: (2020) -
Severe thrombocytopenia following tirofiban infusion
por: Panduranga, Prashanth, et al.
Publicado: (2011) -
Thrombocytopenia in COVID-19 and vaccine-induced thrombotic thrombocytopenia
por: Geronikolou, Styliani A., et al.
Publicado: (2022) -
Trastuzumab Associated With Recurrent Severe Thrombocytopenia and Successful Use of Pertuzumab Monotherapy
por: Huff, Mallorie L, et al.
Publicado: (2022)